Table 2.
Type of Biosensor | Type of Drug | Drug | Biosensor Characteristics | Matrix | Limit/Detection Range | Results | Ref. |
---|---|---|---|---|---|---|---|
Fibre optic | Anticonvulsant | Phenytoin | Autonomous reversible immunosensor: mouse monoclonal IgG | Blood and plasma | 4.45 µM | Viability for quantifying phenytoin in blood, applicable for other haptens in blood | [134] |
Bronchodilator | Theophylline | Fluorescence-based autonomous reversible immunosensor: mouse monoclonal IgG | Serum | 55 µM | Analyte concentrations give rise to a change in the antibody binding equilibrium with changes in fluorescence | [135] | |
SPR | Antibiotic | Vancomycin and Chloroeremomycin | Covalent bacterial wall peptide coupling to a self-assembled monolayer (SAM) on a gold film | Solution buffer | 20 mM 2.5 mM |
Chloroeremomycin is related to bacterial wall peptides, thereby facilitating quantification | [142,143] |
Ciprofloxacin | SPR with a molecularly imprinted polymer (MIP) | Solution buffer | 0.08 µg/L | Sensitive technique for quantifying this type of molecule | [144] | ||
Ampicillin | SPR operated in flow conditions | Solution buffer | 10−3 M to 10−1 M | Technique requiring less time (20 min) without losing sensitivity | [145] | ||
Gentamycin | SPR with a Doppler laser using UV-Vis spectroscopy | Solution buffer | 0.05 ng/mL | Lower detection limit compared to ELISA | [146] | ||
Anticancer | MTX | LSPR with functionalized gold nanoparticles with folic acid (FA-AuNPs) in completion with MTX | Serum | 28 nM | Lower detection limit than that reported for LSPR biosensors (155 Nm) | [125] | |
Anticoagulant | Heparin | Using prolamine and polyethyleneimine as affinity surface | Plasma | 0.2 U/mL | Lower detection limit than that found for previously cited techniques | [149] | |
Opioid | Morphine | Immunoassays using polyclonal antibodies from New Zealand rabbits | Urine | 762–24,4000 pg/mL | This technique enables the sensitive and specific quantification of different opioids such as heroin and morphine | [150] | |
LSPR | Anticancer | MTX | LSPR with functionalized gold nanoparticles with folic acid (FA-AuNPs) | Plasma | 155 nM | This technique provides a new index for quantifying this drug by this type of biosensor | [127] |
Antibiotic | Tobramycin | Transmission localized surface plasmon resonance (T-LSPR), using DNA aptamers | Serum | 0.34 µM | This modification enables the direct detection (without using labels) of a small molecule in a complex matrix | [155] | |
Anticoagulant | Megalatran | LSPR integrated with a microfluidic chip | Solution buffer | 0.9 nM | A pioneering study regarding the use of enantioselective biosensors | [141] | |
Anti-arrhythmic | Digoxin | LSPR with gold nanoparticles | Solution buffer | 2 ng/mL | This device enables the direct low-cost detection of digoxin, as well as being a device that is easy to make and use | [160] | |
SERS | Anticancer | 5-fluorouracil | SERS with silver nanoparticles | Saliva | 150 ng/mL | This study provides a great opportunity since it enables one to quantify a highly toxic drug with genetic variations in its metabolism | [162] |
Antibiotic | Ampicillin | SERS with silver on nanoparticles using hydroxylamine—HCl | Solution buffer | 27 ng/mL | This technique has been compared to LC/MS, with greater sensitivity. It provides an index for quantifying drugs with this type of device | [163] | |
Penicillin G | 29 ng/mL | ||||||
Carbenicillin | 30 ng/mL | ||||||
Penicilloic acid | 28 ng/mL |